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Calmodulin (CaM) is a second messenger protein that has evolved
to bind tightly to a variety of targets and, as such, exhibits low
binding specificity. We redesigned CaM by using a computational
protein design algorithm to improve its binding specificity for one
of its targets, smooth muscle myosin light chain kinase (smMLCK).
Residues in or near the CaMsmMLCK binding interface were
optimized; CaM interactions with alternative targets were not
directly considered in the optimization. The predicted CaM se-
quences were constructed and tested for binding to a set of eight
targets including smMLCK. The best CaM variant, obtained from a
calculation that emphasized intermolecular interactions, showed
up to a 155-fold increase in binding specificity. The increase in
binding specificity was not due to improved binding to smMLCK,
but due to decreased binding to the alternative targets. This
finding is consistent with the fact that the sequence of wild-type
CaM is nearly optimal for interactions with numerous targets.
Identifying the interactions responsible for conveying bindingspecificity in proteins is critical to understanding protein
function and is a prerequisite for the design of novel protein
receptors and ligands. Here, we explore the basis of binding
specificity in calmodulin (CaM). CaM is a ubiquitous Ca2-
binding protein that binds to and regulates a variety of proteins
(1–5). Numerous biochemical studies on CaM (6–9), as well as
several x-ray and NMR structures of CaM-target complexes
(10–17), have revealed many aspects of the target recognition
mechanism in this molecule. CaM usually interacts with proteins
by binding to stretches of 14- to 30-aa residues capable of forming
amphipathic -helices. Although specific interactions between
CaM and its targets differ depending on the target identity, the
general topology of CaM-target complexes remains the same
(Fig. 1). On binding, CaM embraces its targets with its C- and
N-terminal globular domains, inducing a coil–to–helix transition
in the target (18).
CaM has evolved to bind to multiple targets with equally high
affinity and, as such, exhibits low binding specificity. To explore
the nature of the interactions conferring (the lack of) binding
specificity in CaM, we redesigned CaM so it would favor binding
to one of its natural targets, smooth muscle myosin light chain
kinase (smMLCK). Starting from the crystal structure of the
CaM–smMLCK complex (11), we optimized the CaM-binding
interface by using ORBIT (optimization of rotamers by iterative
techniques), a program that has been successfully applied to
protein design and stabilization (19–23). In previous work, we
demonstrated that the binding specificity of CaM could be
improved by redesigning a number of core positions in the
CaM-binding interface (24). The designed 8-fold CaM variant,
CaMcore (designated CaM8 in previous work), exhibited binding
affinity for the desired target that was similar to wild type and
showed an increase in binding specificity of up to 120-fold.
In this study, we sought to increase CaM-binding specificity
further by extending the optimization to boundary and surface
positions in the CaM–smMLCK-binding interface. These posi-
tions, occupied mostly by glutamates, are likely to play a major
role in the CaM target recognition mechanism because of the
positively charged nature of the target sequences. Initially, we
used computational protein design methods that were developed
for stabilization of single proteins (25). However, when these
methods yielded poor results, we refined the computational
procedure for optimization of protein–target complexes by
exploring the use of a modified energy function as well as
different optimization parameters. Finally, we discuss the im-
portance of including negative design when optimizing protein
interfaces for improved binding specificity.
Materials and Methods
Computational Methods. All residues in the CaM–smMLCK crys-
tal structure (11) were divided into core, boundary, and surface
classes as described (19). Eight CaM surface and boundary
positions (positions 14, 83, 87, 114, 116, 120, 123, and 127) that
are within 4 Å of smMLCK were selected for optimization. The
following amino acids were allowed at each of the optimized
positions: Ala, Val, Leu, Ile, Met, Phe, Tyr, Trp, Ser, Thr, Asp,
Asn, His, Glu, Gln, Lys, and Arg. The identities of the core
residues in the CaM–smMLCK interface were set to those of a
previously designed CaM variant, CaMcore (designated CaM8 in
previous work; ref. 24). The side chain conformations of the core
residues, as well as those of the smMLCK residues, were allowed
to change during the optimization. The designed sequences were
obtained by using either previously described procedures (24)
(CaMcore and CaMboundary) or by using the variations described
in the main text (CaMmodboundary
nobias and CaMmodboundary
bias ). Rota-
mer libraries used for the CaM optimizations were based on the
backbone dependent library of Dunbrack and Karplus (26). A
potential energy function that included terms for van der Waals,
electrostatic, and hydrogen bonding interactions, and surface
area-based solvation was used to calculate side chainside chain
and side chainbackbone pairwise interactions as described (19, 25,
27). The calculated energies served as input to a side-chain selection
procedure that used either the Dead-End Elimination theorem
(28, 29) (CaMcore and CaMboundary) or a Monte Carlo algorithm (30,
31) (CaMmodboundary
nobias and CaMmodboundary
bias ). All CaM optimiza-
tions were performed by using SGI R10000 processors (Silicon
Graphics, Mountain View, CA) running at 195 MHz.
Protein Expression. CaM variant genes were constructed by using
a recursive PCR procedure (32) with six primers. Wild-type and
mutant CaM genes were cloned into pET-11 (Novagen) and
expressed by isopropyl -D-thiogalactoside (IPTG) induction in
BL21(DE3) hosts (Invitrogen). Proteins were purified by re-
verse-phase HPLC with a wateracetonitrile gradient containing
0.1% trif luoroacetic acid, lyophilized, and stored at 20°C.
Protein masses were verified by electrospray mass spectroscopy.
Peptide Synthesis. Seven peptides, corresponding to CaM-binding
domains in target proteins, were selected to assess binding to the
CaM variants: smMLCK (-ARRKWQKTGHAVRAIGRLSS-);
skMLCK (-KRRWKKNFIAVSAANRFKKISSSGA-); melittin
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(-QQRKRKIWSILAPLGTTLVKLVAGIG-); spectrin (-KTA-
SPWKSARLMVHTVATFNSIKE-); CaMKI (-AKSKWKQAF-
NATAVVRHMRKLQ-); CaMKII (-LKKFNARRKLKGAIL-
TTMLATRNFS-); and CaMKK (-RFPNGFRKRHGMA-
KVLILTDLRPIRRV-).Theeighthtarget,peptide1(-LKWKKL-
LKLLKKLLKLG-), was designed to bind CaM (33). The pep-
tide targets were synthesized and purified as described (24).
Binding Experiments. Binding of the Trp-containing CaM targets
(smMLCK, skMLCK, melittin, peptide 1, CaMKI, and spectrin)
was measured by fluorescence spectroscopy, and binding of
fluorescently silent targets (CaMKII and CaMKK) to CaM was
assessed by circular dichroism spectroscopy as described (24).
Results and Discussion
Boundary and Surface Optimization with Standard Methods. Eight
boundary and surface positions within 4 Å of the smMLCK
peptide in the CaM–smMLCK structure (11) were selected for
the optimization (Fig. 1). In addition, the 24 CaM core residues
in the CaM-binding interface were allowed to change confor-
mation, but their amino acid identities were fixed to those of
CaMcore, a previously optimized CaM core variant that showed
improved binding specificity for smMLCK (24). All of the
smMLCK residues were allowed to change conformation. For
the first CaM boundary and surface optimization, previously
published computational protein design methods were used. The
optimization produced CaMboundary, a protein with 6 boundary
and surface substitutions in addition to the 8 mutations of
CaMcore, for a total of 14 mutations with respect to wild-type
CaM (CaMwt) (Table 1). CaMboundary was expressed, purified,
and tested for binding to smMLCK by using fluorescence
spectroscopy as described (24). The binding affinity (Kd) was
determined to be 114  80 nM. This value is substantially worse
than the binding affinities observed for CaMwt and CaMcore
(1.8  1.3 and 1.3  0.9 nM, respectively).
To determine the source of CaMboundary’s decreased affinity
for smMLCK, six additional CaM variants were constructed,
each with a single boundary or surface substitution from the
CaMboundary design in addition to the eight core mutations of
CaMcore. Titrations of these variants with smMLCK revealed
that the decrease in CaMboundary’s affinity to smMLCK was
largely due to a single mutation, E87L. This mutation produced
a CaMcore variant, CaMcoreE87L, with a binding affinity of 50 
8 nM. CaMcoreE127Q had a significant but less deleterious effect
on binding, giving a binding affinity of 8.2  2.8 nM. The
remaining four CaMcore mutants (CaMcoreE14D, CaMcoreE83R,
CaMcoreE114I, and CaMcoreL116E) showed no decrease in bind-
ing to smMLCK compared with CaMwt and CaMcore.
Analysis of the Standard Computational Methods. The failure of
CaMboundary to retain tight binding to smMLCK highlighted the
inability of the basic design methods to predict favorable inter-
molecular interactions. This result was not surprising because the
methods were developed for stabilization of isolated proteins
rather than protein–protein interfaces. A similar observation
was recently made for the use of protein folding-optimized
potential functions for describing protein–protein interfaces.
These potentials work well when applied to hydrophobic binding
interfaces (equivalent to the CaMcore design) but fail for hydro-
philic interfaces (equivalent to the CaMboundary design) (34).
Examination of the interactions predicted in the CaMboundary–
smMLCK complex revealed several possible problems with the
computational methods.
In the CaM optimization, all of the molecular interactions
were treated equally whether they were within CaM or between
CaM and smMLCK. Such an approach is likely to produce CaM
sequences with improved intramolecular interactions at the
expense of eliminating favorable CaM–smMLCK intermolecular
interactions, which are clearly important for binding. To address
this problem, we modified the existing energy function, biasing
it toward selection of more favorable intermolecular interac-
tions. A parameter  was introduced into the pairwise portion of
the energy function to enhance the intermolecular side chain
side chain interactions and to attenuate the intramolecular side
chainside chain interactions:
ECaM–t
bias  ECaM–t
nobias
ECaM–CaM
bias  2  ECaM–CaM
nobias
Et–t
bias  2  Et–t
nobias
[1]
Fig. 1. X-ray structure of CaM in complex with smMLCK (PDB code 1CDM)
generated with MOLMOL (40). Ca2 atoms are shown as yellow spheres. The
CaM surface and boundary residues selected for optimization are shown in
red. The core residues in the CaM-binding interface, shown in cyan, and the
smMLCK residues, shown in light yellow, were allowed to change conforma-
tion during the optimization procedure. The identities of the CaM core
residues were fixed to those of CaMcore, a core-optimized CaM variant.
Table 1. Binding of boundary- and surface-optimized CaM variants to smMLCK
Designed positions*
Kd, nM11 12 14 55 76 83 84 87 91 109 114 116 120 123 127 145
CaMwt E F E V M E E E V M E L E E E M 1.8  1.3
CaMcore L Y — I E — Y — I L — — — — — I 1.3  0.9
CaMboundary L Y D I E R Y L I L I E — — Q I 114  83
CaMmodboundary
no-bias L Y — I E R Y K I L I E — K — I 6.1  0.8
CaMmodboundary
bias L Y — I E R Y K I L I E — Q — I 2.3  0.7
*Eight boundary and surface positions in the CaM–smMLCK binding interface were optimized. Dashes indicate sequence identity to CaMwt. Eight core mutations,
shown in bold, were carried over from CaMcore.
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Here, ECaM–t
bias , ECaM–CaM
bias , and Et–t
bias denote the modified energy
functions for the interactions between CaM and the target,
within CaM, and within the target, respectively. ECaM–t
nobias describes
the unbiased intermolecular interactions between CaM and the
target; ECaM–CaM
nobias and Et–t
nobias describe the unbiased intramolec-
ular interactions within CaM and the target, respectively. The
optimal value of the parameter  was estimated to be in the
1.2–1.6 range, which was determined by performing a number of
CaM–smMLCK optimizations and by visually inspecting the
computational results.
An additional concern was the large distance-dependent
dielectric constant (  40r) used in the calculation. Although
historically satisfactory, the use of a large dielectric constant
effectively underemphasized the long-range electrostatics term
in the energy function relative to more local terms such as van
der Waals and hydrogen bonding interactions. Electrostatic
interactions, however, are likely to play a key role in the CaM
target recognition mechanism. Their importance is supported by
the presence of many negatively charged residues in the CaM-
binding interface and the positively charged nature of all known
CaM target sequences. Hence, lowering the dielectric constant
in the CaM boundary- and surface-optimization might help to
restore high binding affinity to smMLCK for the variants
generated. A dielectric constant of 4r was selected because this
value was found to be optimal for the design of -sheet surface
residues (35) and it is in the range of values generally used for
calculations of protein binding free energies (36–38).
The small size of the rotamer library used in the calculation
is also a concern. To reduce computational time, we selected a
rotamer library similar to the one used in previous protein design
calculations. In this library, no expansion about the 1 and 2 side
chain dihedral angles was performed for polar residues, resulting
in a relatively small number of rotamers for the polar amino
acids. However, polar residues are thought to be especially
important for CaM target binding. The absence of appropriate
side chain rotamers could have resulted in selection of CaM
sequences with suboptimal interactions with smMLCK. To re-
duce this concern, a rotamer library that contained rotamers
representing expansion about both 1 and 2 for all amino acids
was used as an option in subsequent calculations.
Redesign of the CaM–smMLCK-Binding Interface Using Modified
Methods. Six additional CaM optimizations were performed with
and without biasing of the energy function, by using dielectric
constants of 4r or 40r, and the standard or large rotamer libraries
(see Table 4, which is published as supporting information on the
PNAS web site). Starting from the minimum-energy solution
obtained for the CaM core optimization, CaMcore, a Monte
Carlo search algorithm (30, 31) was used to optimize the eight
boundary and surface residues in the CaM–smMLCK-binding
interface. A Monte Carlo search algorithm was used (instead of
the dead-end elimination method) to rapidly explore different
computational protocols. Computationally predicted CaM vari-
ants were then constructed, and their binding affinities to
smMLCK were determined.
Two of six tested variants showed good binding to smMLCK.
Both variants were predicted by using a dielectric constant of 4r
and the large rotamer library. The first variant, CaMmodboundary
nobias ,
was obtained without introducing biasing into the energy func-
tion; the second variant, CaMmodboundary
bias , was obtained by using
the biased energy function (Table 1). CaMmodboundary
nobias bound to
smMLCK almost as well as CaMwt and CaMcore, showing a Kd
value of 6.1  0.8 nM (Table 1). CaMmodboundary
bias performed
even better, exhibiting a binding affinity of 2.3  0.7 nM, similar
to that of CaMwt. Analysis of the computational methods and
binding data for all of the variants (see Table 4) suggests that
reducing the dielectric constant to 4r and increasing the rotamer
library size have a roughly equal effect on improving binding
affinity, with each modification improving binding by about a
factor of 4.5. Biasing the energy function to emphasize inter-
molecular interactions provides an additional factor of 2.7 in
binding affinity. Combining the three modifications gives the
maximal improvement. CaMmodboundary
bias was selected for further
analysis.
Binding Specificity of CaMmodboundary
bias . To determine the binding
specificity of CaMmodboundary
bias , we assessed its binding to a set of
seven alternative targets; these targets were not included in the
model used for the CaM optimization calculations. Binding of
CaMmodboundary
bias to the Trp-containing targets (skMLCK, spec-
trin, melittin, peptide 1, and CaMKI) was assessed by fluores-
cence spectroscopy; binding of CaMmodboundary
bias to the fluores-
cently silent targets (CaMKII and CaMKK) was monitored by
circular dichroism spectroscopy. Fig. 2 A and B shows the
titration curves for CaMmodboundary
bias binding to the selected
targets. CaMwt binds to seven of eight targets equally well, with
dissociation constants in the low nM range; weaker binding (Kd
Fig. 2. CaMmodboundary
bias binding to target peptides. (A) Titration curves corresponding to binding of the Trp containing targets to CaMmodboundary
bias monitored
by fluorescence at 318 nm: smMLCK (F), skMLCK (), spectrin (), peptide 1 (), melittin (Œ), and CaMKI (). (B) Titration curves corresponding to binding of
CaMmodboundary
bias to the fluorescently silent targets monitored by circular dichroism: CaMKK (F) and CaMKII (Œ).
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of 28  5 nM) is observed for melittin (Table 2). Binding of
CaMmodboundary
bias to all of the alternative targets except melittin
was reduced with respect to CaMwt. Melittin exhibited similar
binding affinities for CaMmodboundary
bias and CaMwt. Furthermore,
binding of CaMmodboundary
bias to four of seven of the alternative
targets was lowered in comparison to CaMcore. When compared
with CaMcore, CaMmodboundary
bias showed similar binding to spec-
trin, melittin, and CaMKII, and reduced binding to skMLCK,
peptide 1, CaMKI, and CaMKK. The greatest loss (200-fold) in
binding affinity to CaMmodboundary
bias is observed for peptide 1,
which contains a nonnatural target sequence that was engi-
neered to bind CaM without considering specific CaM-target
interactions (33). Particularly noteworthy is the ability of
CaMmodboundary
bias to discriminate against the skMLCK peptide.
Unlike CaMcore, which showed little decrease in binding to
skMLCK, CaMmodboundary
bias exhibits a 6-fold decrease in binding
to this target when compared with CaMwt. The sequence of
skMLCK is very similar to that of smMLCK, and, hence, these
peptides would be expected to present very similar binding
surfaces, making it difficult to discriminate between them.
Overall, CaMmodboundary
bias showed increased binding specificity
compared with CaMwt and CaMcore. CaMmodboundary
bias retained
the tight binding affinity of CaMwt for the desired target and
exhibited a up to 200-fold decrease in binding to the alternative
targets (Table 2).
Analysis of the Interactions Predicted in the Redesigned CaM–smMLCK
Complexes. Six mutations that distinguish CaMboundary from
CaMcore produced almost a 100-fold decrease in binding to the
desired target, smMLCK (Table 1). Among these mutations,
only two had a substantial effect on binding. The E87L mutation
was identified as causing the majority of the decrease in binding
affinity. This result was unexpected because Glu-87 does not
interact with the target in the CaMwt–smMLCK complex.
Rather, it forms an intramolecular salt bridge to Arg-90, the
disruption of which in CaMmodboundary
nobias and CaMmodboundary
bias
does not diminish binding. It is possible that the E87L mutation
reduced binding by decreasing the overall stability of CaMboundary.
The 4-fold drop in binding to smMLCK caused by E127Q in the
CaMboundary background was consistent with the disruption of an
intermolecular salt bridge to an Arg on smMLCK.
Unlike CaMboundary, both molecules predicted by the modified
methods, CaMmodboundary
nobias and CaMmodboundary
bias , retained tight
binding to smMCLK. These results support the use of a stronger
electrostatic potential and a larger rotamer library in the CaM–
smMLCK optimization. Introducing bias into the energy func-
tion to obtain CaMmodboundary
bias resulted in a 3-fold improvement
in Kd relative to CaMmodboundary
nobias (Table 1). At the sequence
level, CaMmodboundary
nobias and CaMmodboundary
bias differ only at posi-
tion 123, where a wild-type glutamate is substituted by a lysine
in CaMmodboundary
nobias and a glutamine in CaMmodboundary
bias . Lys-123
in CaMmodboundary
nobias could reduce binding to smMLCK by form-
ing favorable intramolecular electrostatic interactions with
neighboring glutamates (Glu-120 or Glu-127), at the expense of
forming unfavorable intermolecular electrostatic interactions
with the positively charged target peptide.
These results support previous findings on the importance of
glutamates for the target recognition mechanism of CaM (11, 12,
17). CaMwt is able to bind tightly to a variety of targets by using
a subset of available glutamates in salt-bridge interactions.
Removal of a single intermolecular salt bridge between CaM and
smMLCK produces a 3- to 4-fold reduction in CaM’s binding to
the target.
Fig. 3. Fitness of CaM interacting with the desired target, smMLCK (red), and with alternative targets (blue). The CaMwt sequence lies near the respective
maxima for both the desired target and the alternative targets as indicated by *. Arrows show the change in fitness due to mutations in the CaM sequence
predicted by the optimization.
Table 2. Binding affinities (Kd, nM) of WT and redesigned CaM to selected targets
smMLCK skMLCK Spectrin Melittin Peptide1 CaMKI CaMKII CaMKK
CaMwt 1.8  1.3 3.3  0.8 3.3  1.5 28  5 1.7  0.8 1.7  0.7 5.1  1.5 1.0  3.0
CaMcore 1.3  0.9 4.9  1.2 16  6.0 54  18 147  48 1.3  0.8 54  20 32  13
Decrease in binding* 0.72 1.5 4.8 1.9 86 0.76 11 32
Specificity increase† 1.0 2.1 6.7 2.6 120 1.1 15 44
CaMmodboundary
bias 2.3  0.7 21  3 11  2 33  6 343  66 7  2 27  6 67  28
Decrease in binding* 1.3 6.4 3.3 1.2 202 4.1 5.3 67
Specificity increase† 1.0 4.9 2.6 0.9 155 3.2 4.1 51
*Decrease in binding was calculated by taking the ratio of binding affinities of a CaM variant and CaMwt for a particular target.
†Specificity increase was calculated by taking the ratio of binding affinity of a CaM variant and CaMwt for a particular target and dividing it by the same ratio
for smMLCK.
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Positive vs. Negative Design in Improving CaM-Binding Specificity. In
the present work, we were able to increase the binding specificity
of CaM by optimizing its interactions with the desired target,
smMLCK. However, the increase in binding specificity was not
due to CaM’s improved binding affinity to smMLCK but due to
its decreased binding affinity to the alternative targets. Consid-
ering that the alternative targets were not included in the
optimization procedure, the results seem counterintuitive.
CaM has evolved to bind tightly to a large number of targets.
The fitness of CaMwt is nearly optimal with respect to its
sequence for all CaM targets. Fig. 3 illustrates the change in
fitness of CaM for interactions with its targets during the
computational optimization procedure. The two surfaces rep-
resent the fitness of CaM interacting with the desired target,
smMLCK, and with alternative targets. The computational
optimization of the CaM–smMLCK complex results in sequence
changes that improve or maintain CaM’s ability to bind
smMLCK (Fig. 3). Because no information from the alternative
targets is included in the optimization procedure, the sequence
changes are essentially random with respect to interactions with
the latter targets. Given that the fitness of CaMwt is near optimal
for each CaM-target complex, the probability of increasing
fitness by a random sequence change is very low. Hence, without
directly including negative design in the calculations, we expect
to obtain CaM sequences that on average show decreased
binding affinities to the alternative targets, and thus increased
binding specificity for the desired target. Energies calculated for
CaMwt, CaMcore, and CaMmodboundary
bias in the context of five
available CaM-target complex structures (10–12, 15, 17) support
this argument (Table 3). As expected, the energy of the CaM–
smMLCK complex is decreased (improved) by changing the
sequence from CaMwt to CaMcore to CaMmodboundary
bias . For the
alternative targets, the opposite trend is evident: the energies of
the CaM–target complexes are most favorable for the CaMwt
sequence, less favorable for the CaMcore sequence, and least
favorable for the CaMmodboundary
bias sequence.
The further we move away from the CaMwt sequence, while
improving or preserving the fitness of interaction with the
desired target, the more specificity we achieve. This argument
suggests that simultaneously optimizing a larger number of CaM
positions would increase the chances of obtaining a protein
with increased binding specificity. This finding is indeed con-
firmed by the experimental results: the binding specificity of
CaMmodboundary
bias , which included additional boundary and sur-
face positions, was greater than that of the core design, CaMcore.
Expanding the number of optimization positions could increase
CaM-binding specificity either through the cumulative effect of
multiple, slightly improved interactions or through the effect of
a small number of critical interactions. Although the proposed
model (Fig. 3) accommodates both possibilities, the current data
do not allow us to discriminate between these two extremes. It
is likely, however, that both mechanisms operate to different
extents for different targets.
In recent work on binding specificity design in coiled coils,
Havranek and Harbury (39) showed that both positive and
negative design are necessary to achieve binding specificity for
coiled-coil homodimers and heterodimers. The present work
shows that, in the case of CaM, optimizing its interactions with
only the desired target could be sufficient. Because CaM has a
significantly more complex architecture compared with a coiled
coil, it has a greater number of potential interactions to favor one
target over another. Nevertheless, incorporating negative design
in the optimization of the CaM–target interface is likely to
improve the chances of obtaining increased binding specificity.
Direct incorporation of negative design would ensure that the
optimization procedure generates CaM variants with improved
or maintained fitness for the interaction with the desired target,
while simultaneously decreasing fitness for interactions with the
alternative targets.
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